These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1031016)

  • 21. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma renin activity (PRA) and plasma aldosterone in the adrenal cortex hyperactivity. Studies on 50 hypertensive patients.
    Augustin M; Dumitriu L; Ioaniţiu D; Popovici D; Gabrielescu-Berceanu A; Mănciulescu D; Marinescu I; Mazilu M; Dinulescu E; Tache A
    Endocrinologie; 1984; 22(1):37-45. PubMed ID: 6369502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
    Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
    Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional status of the sympathetic nervous system in patients with essential hypertension and low as well as normal plasma renin].
    Philipp T; Planz J; Schumann G; Lindmar R; Distler A
    Verh Dtsch Ges Inn Med; 1974; 80():253-6. PubMed ID: 4454537
    [No Abstract]   [Full Text] [Related]  

  • 25. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between mineral metabolism and the renin-aldosterone system in human hypertension.
    Lind L; Wide L; Sörensen OH; Ljunghall S
    J Hum Hypertens; 1989 Apr; 3(2):137-40. PubMed ID: 2547951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sympathetic nervous system in primary hypertension.
    Weber MA; Drayer JI
    Miner Electrolyte Metab; 1982 Feb; 7(2):57-66. PubMed ID: 6763142
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
    Distler A
    Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of aldosterone to mild essential hypertension.
    Zozaya JL; Viloria MP; Castro A
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):471-83. PubMed ID: 6364279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential arterial hypertension: plasma and urinary aldosterone alterations.
    Garcia Zozaya JL; Padilla Viloria M; Castro A
    South Med J; 1987 Oct; 80(10):1224-7. PubMed ID: 3310248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
    Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension in the elderly.
    Niarchos AP; Laragh JH
    Mod Concepts Cardiovasc Dis; 1980 Aug; 49(8):43-8. PubMed ID: 6993914
    [No Abstract]   [Full Text] [Related]  

  • 37. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma renin activity, levels of catecholamines and aldosterone in essential arterial hypertension treated with ACE inhibitors. Base values and values after stress].
    Melloni GF; Melloni R; Scarazatti E; Gandini C
    Boll Soc Ital Biol Sper; 1987 Nov; 63(11):1019-26. PubMed ID: 2840936
    [No Abstract]   [Full Text] [Related]  

  • 39. Catecholamines and essential hypertension.
    Robertson D; Nies AS
    J S C Med Assoc; 1977 Dec; 73(12):519-22. PubMed ID: 338988
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
    Khristov V; Maleeva A; Turkolev N
    Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.